Inactive Instrument

News Forbion European Acquisition Corp. Nasdaq

Equities

FRBN.U

KYG3619H1285

Summary

Unlock all the news on all businesses: Never miss an investment opportunity again!

EnGene, Inc. completed the acquisition of Forbion European Acquisition Corp. from a group of shareholders in a reverse merger transaction.	01/11	CI
Forbion European Acquisition Corp.(NasdaqGM:FRBN) dropped from NASDAQ Composite Index	31/23/31	CI
Wall Street Set to Open Higher Monday as Investors Parse Earnings, Await Fed Meeting	30/23/30	MT
Forbion European Acquisition Corp. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	30/23/30	CI
Wall Street Set to Open Higher Friday; Core Inflation Rises 0.3% Matching Forecast	27/23/27	MT
Top Premarket Decliners	25/23/25	MT
Forbion European Acquisition Corp. announced that it has received $1.265 million in funding	13/23/13	CI
Forbion European Acquisition Corp. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023	14/23/14	CI
Forbion European Acquisition Corp. announced that it has received $1.265 million in funding from Forbion Growth Sponsor Feac I B.V.	06/23/06	CI
EnGene, Inc. and Forbion European Acquisition Corp. ("FEAC", Nasdaq: FRBN) Announce Business Combination Agreement to Create Nasdaq-Listed Biotechnology Company Developing Next-Generation Non-Viral, Locally Administered Gene Therapies - Form 8-K	17/23/17	PU
Forbion European Acquisition Corp. entered into a business combination agreement to acquire enGene, Inc from shareholders.	17/23/17	CI
Forbion European Acquisition Corp. announced that it has received $56.891682 million in funding from a group of investors	16/23/16	CI
Forbion European Acquisition Corp. announced that it received $56.891682 million in funding from enGene Holdings, and other investors	16/23/16	CI
Forbion European Acquisition Corp. Reports Earnings Results for the First Quarter Ended March 31, 2023	13/23/13	CI
Forbion European Acquisition Corp. Reports Earnings Results for the Full Year Ended December 31, 2022	31/23/31	CI
Forbion European Acquisition Corp. Auditor Raises 'Going Concern' Doubt	30/23/30	CI
Forbion European Acquisition Corp. announced that it expects to receive $0.9 million in funding	24/23/24	CI
Forbion European Acquisition Corp. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2022	11/22/11	CI
Certain Class B Ordinary Shares of Forbion European Acquisition Corp. are subject to a Lock-Up Agreement Ending on 8-JUN-2022.	08/22/08	CI
Forbion European Acquisition Corp.(NasdaqGM:FRBN) added to NASDAQ Composite Index	07/22/07	CI

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

News Forbion European Acquisition Corp. Nasdaq

Equities

FRBN.U

KYG3619H1285

Summary

Filters